Published in J Pathol on July 01, 2007
Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer (2010) 11.16
Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep (2010) 2.32
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT. Theranostics (2011) 1.25
MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. Mol Pharm (2010) 1.20
Tropism-modification strategies for targeted gene delivery using adenoviral vectors. Viruses (2010) 1.17
Defining the role of integrin alphavbeta6 in cancer. Curr Drug Targets (2009) 1.16
Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res (2009) 1.14
aV integrins and TGF-β-induced EMT: a circle of regulation. J Cell Mol Med (2012) 1.07
High-throughput in vivo screening of targeted molecular imaging agents. Proc Natl Acad Sci U S A (2009) 1.05
Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer. Clin Cancer Res (2011) 1.01
Expression of endoglin (CD105) in cervical cancer. Br J Cancer (2009) 1.01
Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide. Mol Imaging (2009) 0.95
From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker. Bioconjug Chem (2013) 0.95
18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6. J Nucl Med (2013) 0.94
Synthesis and characterization of a high-affinity {alpha}v{beta}6-specific ligand for in vitro and in vivo applications. Mol Cancer Ther (2009) 0.94
Therapeutic targeting of integrin αvβ6 in breast cancer. J Natl Cancer Inst (2014) 0.93
The role of PET/CT in cervical cancer. Front Oncol (2013) 0.93
Genetic ablation of alphav integrins in epithelial cells of the eyelid skin and conjunctiva leads to squamous cell carcinoma. Am J Pathol (2008) 0.92
Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer. Mol Cancer (2008) 0.91
Pathophysiology of fistula formation in Crohn's disease. World J Gastrointest Pathophysiol (2014) 0.87
Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer. Sci Rep (2014) 0.86
Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer. Gastric Cancer (2014) 0.85
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus. J Mol Biol (2008) 0.85
αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer. Clin Exp Metastasis (2014) 0.85
A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density. PLoS One (2013) 0.85
99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging. Mol Pharm (2014) 0.84
Role of IL-12p40 in cervical carcinoma. Br J Cancer (2012) 0.84
Chemically programmed antibodies targeting multiple alpha(v) integrins and their effects on tumor-related functions in vitro. Bioconjug Chem (2011) 0.84
Expression and mutational analysis of TGF-beta/Smads signaling in human cervical cancers. J Gynecol Oncol (2009) 0.84
Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆. Bioorg Med Chem (2011) 0.83
Prostate carcinoma and radiation therapy: therapeutic treatment resistance and strategies for targeted therapeutic intervention. Expert Rev Anticancer Ther (2008) 0.81
Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion. J Cell Sci (2015) 0.80
The role of integrins in TGFβ activation in the tumour stroma. Cell Tissue Res (2016) 0.80
Correlations between integrin ανβ6 expression and clinico-pathological features in stage B and stage C rectal cancer. PLoS One (2014) 0.78
The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake. J Nucl Med (2015) 0.78
Molecular targets for radiation oncology in prostate cancer. Front Oncol (2011) 0.78
Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6. Mol Imaging Biol (2014) 0.77
Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect. Theranostics (2014) 0.77
Molecular imaging of integrin αvβ6 expression in living subjects. Am J Nucl Med Mol Imaging (2014) 0.77
Generation and characterization of a diabody targeting the αvβ6 integrin. PLoS One (2013) 0.77
Targeting of the β6 gene to suppress degradation of ECM via inactivation of the MAPK pathway in breast adenocarcinoma cells. Oncol Rep (2014) 0.77
Structural guided scaffold phage display libraries as a source of bio-therapeutics. PLoS One (2013) 0.76
Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer. Onco Targets Ther (2016) 0.76
Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies. Oncotarget (2016) 0.75
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells. Mol Ther (2017) 0.75
Application of a novel method of double APAAP staining with subsequent quantitative image analysis to the examination of integrin expression in undifferentiated-type gastric carcinomas. J Histochem Cytochem (2009) 0.75
Pro-migratory and TGF-β-activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch. J Pathol (2017) 0.75
Integrins as Therapeutic Targets: Successes and Cancers. Cancers (Basel) (2017) 0.75
Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest (1978) 4.83
Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetases. Biochemistry (1998) 3.96
Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin. Chem Biol (1998) 3.89
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res (1988) 3.31
Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol (1995) 3.06
Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol (1994) 2.84
[Morbidity and results of 100 radical hysterectomies performed in an oncology center]. Ned Tijdschr Geneeskd (1992) 2.67
Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol (1997) 2.27
Post-translational modification of polyketide and nonribosomal peptide synthases. Curr Opin Chem Biol (1997) 2.05
PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Hum Pathol (2000) 1.77
The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem Biol (1995) 1.71
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet (2003) 1.69
Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer (2003) 1.61
A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer (2001) 1.59
Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer (1994) 1.59
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci U S A (2001) 1.55
Objective assessment of sexual arousal in women with a history of hysterectomy. BJOG (2004) 1.53
Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. IV. Investigations into the pathogenesis of the model. Lab Invest (1978) 1.52
Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res (1999) 1.49
Enhanced potency of human Sonic hedgehog by hydrophobic modification. Biochemistry (2001) 1.49
Why do child mortality rates fall? An analysis of the Nicaraguan experience. Am J Public Health (1991) 1.45
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial. Eur J Cancer (1999) 1.44
Association between HLA-expression and infiltration of immune cells in cervical carcinoma. Lab Invest (1993) 1.44
Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes. J Exp Med (1997) 1.40
Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol (1987) 1.38
The influence of phagocyte function on glomerular localization of aggregated IgM in rats. Clin Exp Immunol (1978) 1.38
Parvovirus B19 associated with fetal abnormality. Lancet (1987) 1.37
Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia. Int J Gynecol Cancer (2006) 1.35
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J Clin Oncol (1993) 1.35
CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol (1986) 1.33
Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol (2001) 1.32
Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab Invest (1992) 1.32
Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule. Mol Cell Biol (1998) 1.32
Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior. J Bone Joint Surg Am (1994) 1.31
IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes. Immunology (1987) 1.30
Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol (1996) 1.25
Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol (2000) 1.25
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes. Int J Cancer (2001) 1.25
Visualising scanning patterns of pathologists in the grading of cervical intraepithelial neoplasia. J Clin Pathol (2003) 1.24
Cervical tissue shrinkage by formaldehyde fixation, paraffin wax embedding, section cutting and mounting. Virchows Arch A Pathol Anat Histopathol (1983) 1.23
The value of immunohistochemistry for collagen IV expression in colorectal carcinomas. Cancer (1991) 1.22
The pathogenetic role of free-circulating antibody in autologous immune complex glomerulonephritis. Clin Exp Immunol (1980) 1.21
Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med (2000) 1.19
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope. Cancer Res (1996) 1.18
Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol (1988) 1.18
Activation of complement by human serum IgA, secretory IgA and IgA1 fragments. Mol Immunol (1988) 1.15
Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence. Br J Obstet Gynaecol (1987) 1.15
Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity. Br J Cancer (1994) 1.14
ras oncogene activation in human ovarian carcinoma. Oncogene (1988) 1.13
Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours. J Pathol (1997) 1.11
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases. Genes Chromosomes Cancer (2000) 1.10
Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. J Clin Oncol (1994) 1.10
Demonstration of antinuclear antibodies in mercuric chloride-induced glomerulopathy in the rat. Lab Invest (1978) 1.10
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma. J Immunother (2000) 1.09
Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am J Pathol (1999) 1.09
The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol (2006) 1.08
Homeobox genes in mouse development. Crit Rev Eukaryot Gene Expr (1991) 1.07
Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response. Hum Pathol (1996) 1.06
Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene (2012) 1.06
Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma. Int J Cancer (2013) 1.05
Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin Exp Immunol (1990) 1.05
CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients. Br J Cancer (2012) 1.05
Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. Cancer Res (1999) 1.05
The value of tumour marker CA 125 in surgical pathology. Histopathology (1987) 1.04
Feasibility of in situ hybridisation with chromosome specific DNA probes on paraffin wax embedded tissue. J Clin Pathol (1991) 1.03
Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Int J Cancer (2011) 1.03
Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. Am J Pathol (1986) 1.03
Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma. J Pathol (2008) 1.03
The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas. Br J Cancer (1998) 1.02
An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer (2006) 1.02
Detection of trisomy 8 in hematological disorders by in situ hybridization. Cytogenet Cell Genet (1991) 1.02
The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2. J Pathol (2006) 1.02
Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gynecol Oncol (2000) 1.02
Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol (2001) 1.01
Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest (2001) 1.01
Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int J Gynecol Cancer (2006) 1.01
Expression of endoglin (CD105) in cervical cancer. Br J Cancer (2009) 1.01
HIV/AIDS-related knowledge, attitudes, and practices among Managuan secondary school students. Bull Pan Am Health Organ (1993) 1.00
Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells. Biochim Biophys Acta (1999) 1.00
New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency. Cancer Res (1994) 1.00
Human leukocyte antigen class I gene mutations in cervical cancer. J Natl Cancer Inst (1999) 0.99
The extracellular matrix in pathology. J Lab Clin Med (1988) 0.99
The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cells. J Clin Pathol (1998) 0.99
Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the alpha2beta1 integrin. Biochemistry (2000) 0.99